Selected research
Market Structure
Global Sterile and Antiviral Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sterile and Antiviral Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sterile and Antiviral Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sterile and Antiviral Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sterile and Antiviral Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sterile and Antiviral Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sterile and Antiviral Packaging include Dupont, BillerudKorsnas, Amcor, Placon Corporation, Sonoco Products, Oliver Healthcare Packaging, Ampac Holdings and Wipak Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sterile and Antiviral Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sterile and Antiviral Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sterile and Antiviral Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sterile and Antiviral Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.
Sterile and Antiviral Packaging Segment by Company
Dupont
BillerudKorsnas
Amcor
Placon Corporation
Sonoco Products
Oliver Healthcare Packaging
Ampac Holdings
Wipak Group
Sterile and Antiviral Packaging Segment by Type
Plastic Material
Glass Material
Metallic Material
Other
Sterile and Antiviral Packaging Segment by Application
Pharmaceutical & Biological
Surgical & Medical Instruments
Food & Beverage Packaging
Others
Sterile and Antiviral Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile and Antiviral Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sterile and Antiviral Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile and Antiviral Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sterile and Antiviral Packaging market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile and Antiviral Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sterile and Antiviral Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sterile and Antiviral Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Plastic Material
- Glass Material
- Metallic Material
- Other
Applications
- Pharmaceutical & Biological
- Surgical & Medical Instruments
- Food & Beverage Packaging
- Others
Companies covered
- Dupont
- BillerudKorsnas
- Amcor
- Placon Corporation
- Sonoco Products
- Oliver Healthcare Packaging
- Ampac Holdings
- Wipak Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sterile and Antiviral Packaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sterile and Antiviral Packaging Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sterile and Antiviral Packaging Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sterile and Antiviral Packaging Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sterile and Antiviral Packaging Market Dynamics
- 2.1 Sterile and Antiviral Packaging Industry Trends
- 2.2 Sterile and Antiviral Packaging Industry Drivers
- 2.3 Sterile and Antiviral Packaging Industry Opportunities and Challenges
- 2.4 Sterile and Antiviral Packaging Industry Restraints
3 Sterile and Antiviral Packaging Market by Manufacturers
- 3.1 Global Sterile and Antiviral Packaging Revenue by Manufacturers (2021-2026)
- 3.2 Global Sterile and Antiviral Packaging Sales by Manufacturers (2021-2026)
- 3.3 Global Sterile and Antiviral Packaging Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sterile and Antiviral Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sterile and Antiviral Packaging Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sterile and Antiviral Packaging Manufacturers, Product Type & Application
- 3.7 Global Sterile and Antiviral Packaging Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sterile and Antiviral Packaging Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sterile and Antiviral Packaging Players Market Share by Revenue in 2025
- 3.8.3 2025 Sterile and Antiviral Packaging Tier 1, Tier 2, and Tier 3
4 Sterile and Antiviral Packaging Market by Type
- 4.1 Sterile and Antiviral Packaging Type Introduction
- 4.1.1 Plastic Material
- 4.1.2 Glass Material
- 4.1.3 Metallic Material
- 4.1.4 Other
- 4.2 Global Sterile and Antiviral Packaging Sales by Type
- 4.2.1 Global Sterile and Antiviral Packaging Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sterile and Antiviral Packaging Sales by Type (2021-2032)
- 4.2.3 Global Sterile and Antiviral Packaging Sales Market Share by Type (2021-2032)
- 4.3 Global Sterile and Antiviral Packaging Revenue by Type
- 4.3.1 Global Sterile and Antiviral Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sterile and Antiviral Packaging Revenue by Type (2021-2032)
- 4.3.3 Global Sterile and Antiviral Packaging Revenue Market Share by Type (2021-2032)
5 Sterile and Antiviral Packaging Market by Application
- 5.1 Sterile and Antiviral Packaging Application Introduction
- 5.1.1 Pharmaceutical & Biological
- 5.1.2 Surgical & Medical Instruments
- 5.1.3 Food & Beverage Packaging
- 5.1.4 Others
- 5.2 Global Sterile and Antiviral Packaging Sales by Application
- 5.2.1 Global Sterile and Antiviral Packaging Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sterile and Antiviral Packaging Sales by Application (2021-2032)
- 5.2.3 Global Sterile and Antiviral Packaging Sales Market Share by Application (2021-2032)
- 5.3 Global Sterile and Antiviral Packaging Revenue by Application
- 5.3.1 Global Sterile and Antiviral Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sterile and Antiviral Packaging Revenue by Application (2021-2032)
- 5.3.3 Global Sterile and Antiviral Packaging Revenue Market Share by Application (2021-2032)
6 Global Sterile and Antiviral Packaging Sales by Region
- 6.1 Global Sterile and Antiviral Packaging Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sterile and Antiviral Packaging Sales by Region (2021-2032)
- 6.2.1 Global Sterile and Antiviral Packaging Sales by Region (2021-2026)
- 6.2.2 Global Sterile and Antiviral Packaging Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sterile and Antiviral Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sterile and Antiviral Packaging Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sterile and Antiviral Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sterile and Antiviral Packaging Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sterile and Antiviral Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sterile and Antiviral Packaging Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sterile and Antiviral Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sterile and Antiviral Packaging Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sterile and Antiviral Packaging Revenue by Region
- 7.1 Global Sterile and Antiviral Packaging Revenue by Region
- 7.1.1 Global Sterile and Antiviral Packaging Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sterile and Antiviral Packaging Revenue by Region (2021-2026)
- 7.1.3 Global Sterile and Antiviral Packaging Revenue by Region (2027-2032)
- 7.1.4 Global Sterile and Antiviral Packaging Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sterile and Antiviral Packaging Revenue (2021-2032)
- 7.2.2 North America Sterile and Antiviral Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sterile and Antiviral Packaging Revenue (2021-2032)
- 7.3.2 Europe Sterile and Antiviral Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sterile and Antiviral Packaging Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sterile and Antiviral Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sterile and Antiviral Packaging Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sterile and Antiviral Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Dupont
- 8.1.1 Dupont Company Information
- 8.1.2 Dupont Business Overview
- 8.1.3 Dupont Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Dupont Sterile and Antiviral Packaging Product Portfolio
- 8.1.5 Dupont Recent Developments
- 8.2 BillerudKorsnas
- 8.2.1 BillerudKorsnas Company Information
- 8.2.2 BillerudKorsnas Business Overview
- 8.2.3 BillerudKorsnas Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BillerudKorsnas Sterile and Antiviral Packaging Product Portfolio
- 8.2.5 BillerudKorsnas Recent Developments
- 8.3 Amcor
- 8.3.1 Amcor Company Information
- 8.3.2 Amcor Business Overview
- 8.3.3 Amcor Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Amcor Sterile and Antiviral Packaging Product Portfolio
- 8.3.5 Amcor Recent Developments
- 8.4 Placon Corporation
- 8.4.1 Placon Corporation Company Information
- 8.4.2 Placon Corporation Business Overview
- 8.4.3 Placon Corporation Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Placon Corporation Sterile and Antiviral Packaging Product Portfolio
- 8.4.5 Placon Corporation Recent Developments
- 8.5 Sonoco Products
- 8.5.1 Sonoco Products Company Information
- 8.5.2 Sonoco Products Business Overview
- 8.5.3 Sonoco Products Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sonoco Products Sterile and Antiviral Packaging Product Portfolio
- 8.5.5 Sonoco Products Recent Developments
- 8.6 Oliver Healthcare Packaging
- 8.6.1 Oliver Healthcare Packaging Company Information
- 8.6.2 Oliver Healthcare Packaging Business Overview
- 8.6.3 Oliver Healthcare Packaging Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Oliver Healthcare Packaging Sterile and Antiviral Packaging Product Portfolio
- 8.6.5 Oliver Healthcare Packaging Recent Developments
- 8.7 Ampac Holdings
- 8.7.1 Ampac Holdings Company Information
- 8.7.2 Ampac Holdings Business Overview
- 8.7.3 Ampac Holdings Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ampac Holdings Sterile and Antiviral Packaging Product Portfolio
- 8.7.5 Ampac Holdings Recent Developments
- 8.8 Wipak Group
- 8.8.1 Wipak Group Company Information
- 8.8.2 Wipak Group Business Overview
- 8.8.3 Wipak Group Sterile and Antiviral Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Wipak Group Sterile and Antiviral Packaging Product Portfolio
- 8.8.5 Wipak Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sterile and Antiviral Packaging Value Chain Analysis
- 9.1.1 Sterile and Antiviral Packaging Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sterile and Antiviral Packaging Production Mode & Process
- 9.2 Sterile and Antiviral Packaging Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sterile and Antiviral Packaging Distributors
- 9.2.3 Sterile and Antiviral Packaging Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst